From Prague to Seattle: Improved Endoscopic Technique and Reporting Improves Outcomes in Patients with Barrett's Esophagus

Brown, J.; Sharma, P.
January 2016
Digestive Diseases & Sciences;Jan2016, Vol. 61 Issue 1, p4
Academic Journal
No abstract available.


Related Articles

  • Risk factors for Barrett's esophagus: a scoping review. Ireland, Colin; Thompson, Sarah; Laws, Thomas; Esterman, Adrian; Ireland, Colin J; Thompson, Sarah K; Laws, Thomas A // Cancer Causes & Control;Mar2016, Vol. 27 Issue 3, p301 

    Introduction: Cancer of the esophagus is a highly lethal disease with many patients presenting with metastatic spread of their tumor at diagnosis; a consequence of this late presentation is the 5-year survival rate of <20 %. Barrett's esophagus (BE), a premalignant condition of...

  • Endoscopic treatment for Barrett's oesophagus dysplasia and early cancer. Pana, Mirela; Sansone, Stefano; Ortiz Fernandez-Sordo, Jacobo; Ragunath, Krish // Gastrointestinal Nursing;Jul/Aug2017, Vol. 15 Issue 6, p18 

    Endoscopic treatment of early Barrett's oesophagus neoplasia is now proven to be a safe and effective alternative to oesophagectomy. An ideal candidate for endoscopic treatment should have dysplasia or carcinoma limited to the mucosa or superficial submucosa without lymphovascular invasion or...

  • Expert pathology review and endoscopic mucosal resection alters the diagnosis of patients referred to undergo therapy for Barrett's esophagus. Ayers, Katie; Shi, Chanjuan; Washington, Kay; Yachimski, Patrick // Surgical Endoscopy;Aug2013, Vol. 27 Issue 8, p2836 

    Background: Endoscopic therapy has emerged as an alternative to surgical esophagectomy for the management of Barrett's esophagus (BE)-associated neoplasia. Accurate pretreatment staging is essential to ensure an appropriate choice of therapy and optimal long-term outcomes. This study aimed to...

  • One minute with...Laura Esserman. O'Callaghan, Tiffany // New Scientist;8/10/2013, Vol. 219 Issue 2929, p27 

    An interview with cancer specialist Laura Esserman is presented. When asked about why she has developed new recommendations for cancer screening she says that current perceptions of cancer fail to account for differences in cancers. She talks about the need to research the reaction of...

  • A labelled discrete choice experiment adds realism to the choices presented: preferences for surveillance tests for Barrett esophagus. Kruijshaar, Michelle E.; Essink-Bot, Marie-Louise; Donkers, Bas; N. Looman, Caspar W.; Siersema, Peter D.; Steyerberg, Ewout W. // BMC Medical Research Methodology;2009, Vol. 9, Special section p1 

    Background: Discrete choice experiments (DCEs) allow systematic assessment of preferences by asking respondents to choose between scenarios. We conducted a labelled discrete choice experiment with realistic choices to investigate patients' trade-offs between the expected health gains and the...

  • Predicting regression of Barrett's esophagus: results from a retrospective cohort of 1342 patients. Brown, Craig; Lapin, Brittany; Wang, Chi; Goldstein, Jay; Linn, John; Denham, Woody; Haggerty, Stephen; Talamonti, Mark; Howington, John; Carbray, Joann; Ujiki, Michael // Surgical Endoscopy;Oct2014, Vol. 28 Issue 10, p2803 

    Introduction: Barrett's esophagus (BE) is the most predictive risk factor for development of esophageal adenocarcinoma (EAC), a malignancy with the fastest increasing incidence in the US. The aim of this study was to investigate differences in exposures, demographics, and comorbidities between...

  • Room for Quality Improvement in Endoscopist-Directed Sedation: Results from the First Nationwide Survey in Korea. Chang Kyun Lee; Seok Ho Dong; Eun Sun Kim; Sung-Hoon Moon; Hong Jun Park; Dong-Hoon Yang; Young Chul Yoo; Tae Hoon Lee; Sang Kil Lee; Jong Jin Hyun // Gut & Liver;Jan2016, Vol. 10 Issue 1, p83 

    Background/Aims: This study sought to characterize the current sedation practices of Korean endoscopists in real-world settings. Methods: All active members of the Korean Society of Gastrointestinal Endoscopy were invited to complete an anonymous 35-item questionnaire. Results: The overall...

  • Barrett's esophagus: an exaggerated risk? Bisschops, Raf // Annals of Gastroenterology;Jan2012, Vol. 25, p79 

    Over the last decade, the therapy of early Barrett's neoplasia has significantly changed by the introduction of endoluminal therapy. Nowadays, endoscopic resection of mucosal cancer in combination with radiofrequency ablation of the remaining Barrett's epithelium, has replaced surgery as a first...

  • Perceptions of risk and therapy among patients with Barrett's esophagus: a patient survey study. Stier, M W; Lodhia, N; Jacobs, J; Nozicka, D; Kavitt, R; Siddiqui, U; Waxman, I; Konda, V J // Diseases of the Esophagus;Apr2018, Vol. 31 Issue 4, pN.PAG 

    SUMMARY: Nondysplastic Barrett's esophagus has a risk of progression to esophageal adenocarcinoma as low as 0.18–0.3% per person per year, and low-grade dysplasia as low as 0.5%. While adherence to guidelines and selection of management options varies, little is known about what modifies...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics